skip to content
Home

Zoonoses Associated with Laboratory Animals

Campylobacteriosis

Etiology: Campylobacter jejuni, C. fetus, C. laridis.

Significance: Moderate to high.

Hosts: Man and non-human primates, cattle, sheep, poultry, dogs, kittens, swine, rodents. Campylobacter jejuni is common in all species of nonhuman primates.

Transmission: Ingestion of meat contaminated with intestinal contents, contaminated water, contact with animals. Asymptomatic shedding by primates is common.

Clinical disease: Clinical signs of campylobacter infection are variable in both animals and humans. They range from asymptomatic infection to acute typhoid-like illness. Recurrent symptoms are reported. Immunological phenomena such as reactive arthritis are possible sequelae to infection. Diagnosis is by fecal culture.

Treatment/control: Supportive care (oral electrolytes) and antibiotics (erythromycin). Mild cases may resolve without antibiotics. Carrier states are common. Colony primates should be tested regularly and isolated and treated if positive. Precautions against exposure include protective clothing, shoe and head covers, face masks and gloves whenever in contact with nonhuman primates.

Dermatophytosis (Ringworm)

Agent: Dermatophytic fungi: Microsporum canis, Trichophyton mentagrophytes

Significance: Low

Host: Most mammals

Transmission: Direct contact with infected skin or hair

Clinical disease: Itchy red papule that spreads with central clearing resulting in a ring-like appearance.

Treatment/control: Topical or systemic antifungal drugs.

Herpes B Virus


Etiology: Herpesvirus simiae-a herpesviruse host adapted to non-human primates

Significance: High-infection in humans is nearly uniformly fatal

Host: Herpes B virus is present in about 25% of rhesus and cynomolgus monkeys; only 2-3% of these monkeys have clinical signs at a given time. Herpes B virus does not infect baboons, squirrel monkeys or owl monkeys.

In general, herpes viruses are species adapted and do not cause disease in their natural hosts but infection can be fatal to other primate species.
For instance, Herpesvirus saimiri and Herpesvirus tamarinus cause no clinical disease in squirrel monkeys but are lethal in owl monkeys and marmosets. Human herpes viruses are highly pathogenic for owl monkeys and marmosets. Herpes viruses are common in other primate species but are not hazardous to humans.

Animal care workers should take care to avoid cross contamination between these species by shared equipment. Animal care and research personnel should not work with New World species when they have active cold sore lesions.

Transmission: Infection of man may occur after bites, scratches, needle sticks, splashes to the eye or injuries caused by macaque caging. Virus is shed from active herpetic lesions and in any body fluids.

Clinical disease: While herpes B virus infection of humans is very rare, when it occurs the disease is often fatal. The incubation period of the disease in man is between 2 weeks and 6 months. Pain, numbness and weakness of the affected arm may occur, accompanied by generalized malaise and flu-like symptoms. Coma and death result from central nervous system infection. Infected animals may have very minor illness, with conjunctivitis or ulcers or white plaques on the lips, nares, tongue, palate or genitalia.

Treatment/control: Diagnosis of Herpes B infection in monkeys is complicated because infected animals may not have detectable antibody and shed virus only intermittently. Thus, all macaque monkeys must be assumed to be potential carriers of this virus. Safe handling procedures to avoid bites and scratches are essential. All injuries to humans caused by macaques or mucosal exposures to macaque body fluids and injuries sustained by personnel from cage equipment have potential to transmit Herpes B. Use of appropriate protective clothing, especially a facemask, cannot be overemphasized. In the event of an injury, washing the wound [Link] for 15 minutes is the most important first step. The injured employee must report the injury to the supervisor, the attending veterinarian and occupational health services so that appropriate evaluation of both human and primate is begun. Once a wound has been acutely managed, any unusual symptoms that develop later must be promptly reported.


Lymphocytic Chorio-meningitis Virus (LCMV)

Agent: Arenavirus

Significance: High. Infection of wild rodent populations is not uncommon.

Host: Mice, hamsters, guinea pigs, human

Transmission: Aerosolization of urine, contaminated dust or bedding, fecal contamination

Clinical disease: In humans, often a flu-like illness with fever progressive to meningitis or encephalitis. LCMV infection is asymptomatic in animal hosts.

Treatment/control: Treatment of clinical disease is difficult. Control involves routine screening of rodents, guinea pigs and hamsters for seroconversion and culling of any seropositive animals. Introduction of virus into animal colonies through contaminated cell lines has occurred. Prescreening of cell lines intended for introduction into colony animals is essential.

Measles Virus

Etiology: Paramyxovirus

Significance: Moderate, since vaccination protection is not complete in all people

Hosts: Nonhuman primates (New World monkeys are more susceptible to measles than are Old World monkeys), puppies, humans

Transmission: Contact, aerosol of respiratory particles

Clinical disease: The incubation period in monkeys is usually 5-15 days. Affected animals develop conjunctivitis, lethargy, and a diffuse rash. Pneumonia, abortion, secondary bacterial infection and death can occur.

Treatment/control: Measles is rare in wild monkeys but unvaccinated monkeys acquire the disease readily from other monkeys or from infected people. Unvaccinated or improperly vaccinated people may contract the disease from monkeys during an outbreak. Improperly vaccinated people may introduce the infection into a primate colony.

Orf (Contagious Ecythma)

Agent: Parapoxvirus

Significance: Moderate

Host: Sheep and goats, human

Transmission: Direct skin contact with infected tissue, scabs, or contaminated bedding or equipment

Clinical disease: In sheep and goats, infection with parapoxvirus causes proliferative papules or crusted vesicles on the skin of the lips, nostrils, around the eyes or on teats of nursing females. The infection is very contagious, but causes little mortality, unless nursing is inhibited in lambs or goat kids. In humans large nodules with surrounding inflamed skin can occur. The lesions may itch and disappear slowly after 4-6 weeks.

Treatment/control: There is little treatment for lesions, but control is through use of good hygiene practices when handling ruminants. Whenever suspicious oral lesions are seen, the use of protective clothing (esp. gloves) is essential to prevent exposure. Procurement of small ruminants from reputable dealers, rather than use of random source or auctioned animals decreases chance of infection in experimental animals.

Q Fever

Etiology: Coxiella burnetti, a rickettsia.

Significance: Moderate to high-- the agent is widespread, and the potential for chronic, debilitating disease exists.

Hosts: Livestock, especially sheep and goats, birds, and humans.

Transmission: The organism is shed in urine, feces and milk during active infection. The organism is concentrated in amnionic fluid, placenta, and fetal membranes. Thus experiments involving ovine fetal surgery or allowing birth of lambs have the greatest potential for exposure of investigators and animal care personnel. The organism is spread by aerosol from fetal membranes and fluids, or contaminated bedding.

Clinical Disease: Infection in animals is generally asymptomatic. In humans, symptoms of fever, headache and chills develop after a 14-28 day incubation period. Most patients develop a self-limiting illness of only 2 weeks duration, but some individuals develop liver disease or cardiac valve endocarditis. Exposure of immunosuppressed individuals or those having had a cardiac valve replacement is of greatest concern. Diagnosis is by serology.

Treatment/control: Control is best accomplished by the use of sheep from Q-fever negative flocks. If this is not possible, testing of individual females before use in peri-parturient studies and rejection of any animals with positive serology is advisable. Use of male sheep or goats decreases risk. When peri-parturient animals, fetal membranes or newborn lambs are handled, BL-2 precautions must be in place, including protective clothing, shoe and head covers, facemask and gloves. Peri-parturient animal must be transported in filtered cages, and bedding collected withing for 48 hours after birth should be decontaminated.

Immunocompromised individuals, including those with a positive test for the AIDS virus, or those with congenital cardiac disease or valvular disease should not work with sheep or goats at the time of parturition.

Rabies Virus

Etiology: Rhabdovirus

Significance: Low in terms of incidence and potential exposure from laboratory animals; high risk in dealing with wild populations especially of bats. The consequences of infection are very severe.

Hosts: Most mammals. Common wild animal reservoirs include skunks, raccoons, foxes, coyotes, and bats. Rodents and rabbits are not known to be naturally infected.

Transmission: Saliva (bite or scratch) from an infected animal, contact with tissue from an infected animal, inhalation of aerosolized virus

Clinical disease: A latent period of weeks, months or years can occur. Symptoms begin with fatigue, malaise or headache and progress to severe central nervous system disease with paralysis, coma and death. Numbness or tingling at the bite or scratch site may be the initial sign. Rabies is almost uniformly fatal once clinical disease develops. It is important to note that the initial clinical signs in animals are highly variable and nonspecific. Any abnormal behavior in wild-caught unvaccinated animals should arouse suspicion and extreme precautions.

Treatment/control: Consider any wild-caught or random source mammals as potentially infected and exercise extreme care in handling these animals. Appropriate protective clothing and restraint procedures must be used when handling them. All personnel whose work places them in contact with such animals should be vaccinated with human diploid cell vaccine. All bites or scratches from potentially rabid animals must be reported immediately to an animal care supervisor and attending veterinarian so that appropriate diagnostic evaluation can be arranged.


Shigellosis

Etiology: Shigella flexneri, S. boydii, S. sonnei, S. dysenteriae

Significance: Very high.

Hosts: Humans and primates. Shigella flexneri is a common cause of diarrhea in macaque monkeys. Humans may also be the reservoir for monkey infections, but asymptomatic carriers may maintain the infection in the colony between outbreaks.

Transmission: Fecal-oral. Shigella is very infectious and as few as 500 bacteria will causes infection. Children are more susceptible than adults.

Clinical disease: Diarrhea with blood and mucous is the most common clinical sign. Shigellosis may be fatal in monkeys if untreated, but most animals respond rapidly to antibiotics and parenteral fluids. The human disease is often mild in adults, but may be very debilitating or fatal in children. Monkeys also may harbor other bacteria that cause debilitating diarrhea in people, and may shed large numbers of bacteria in their feces without serious illness. People may also shed these bacteria asymptomatically. Diagnosis of all of these infections is by culture of the feces.

Treatment/control:Multi-antibiotic resistant strains are present throughout the world. All nonhuman primates should have regular fecal cultures, and any infected animals should be isolated and treated. Appropriate protective clothing, shoe and head covers and gloves when in contact with nonhuman primates are of greatest importance in preventing exposure. Prevention of fecal contact with any equipment that may subsequently contact hands or mouth must be prevented.


Tuberculosis

Etiology: Mycobacterium tuberculosis

Significance: High

Hosts: All non-human primates. Tuberculosis is rare in wild monkeys but can readily be acquired from infected humans.

Transmission: Aerosol of infectious particles from respiratory secretions

Clinical disease: People may have asymptomatic infections or may suffer severe respiratory disease and weight loss. Routine tuberculin testing detects most human cases in non-vaccinated populations. Chest radiographs are required to make a positive diagnosis of disease in BCG-vaccinated people.

Treatment/control: Tuberculosis causes severe weight loss, lethargy and coughing and is almost always fatal in monkeys, but the disease can go unrecognized for months during which time other animals may be infected. Strict quarantine of new animals and regular testing of the entire colony identifies asymptomatic monkeys. Old world primates are tested quarterly and New world primates are tested annually. All personnel who work with primates should be tuberculin tested annually. Infected animals are not treated, but are culled from the colony. Treament of humans requires a prolonged course of systemic antibiotics.

All individuals who work with monkeys, including visiting faculty and students, must have annual skin tests showing that they do not have tuberculosis. Individuals with positive skin tests must have an alternate evaluation such as a chest radiograph by a health professional within the calendar year prior to working with primates.

Harvard Medical School staff and students may obtain tuberculin skin tests or radiographs at no charge from the University Health Services. Individuals with other primary affiliations should be tested at their home institution. Written documentation of tuberculin skin test results must be presented to the ARCM Associate Director for Operations before requesting access to nonhuman primate facilities.


Immunodeficiency Viruses

Etiology: Various retroviruses
Significance: Unknown
Hosts: Non-Human Primates, primarily old world monkeys and apes; Humans
Transmission: Cell associated transmission; blood borne.
Treatment: Anti-retroviral therapy

Infection of monkeys with simian Immunodeficiency Virus (SIV) causes an AIDS-like syndrome in macaques but only occurs in experimental infectious disease laboratories. There are no macaques infected with SIV at the Longwood campus. SIV is not known to be pathogenic to people, but it is closely related to human immunodeficiency virus (HIV) and the virus can infect human cells in tissue culture. Type D retrovirus is another immunosuppressive macaque retrovirus that can cause diarrhea, weight loss and recurrent infections. Macaques at the Longwood Medical Area are regularly screened for this virus to prevent inadvertent introduction of infected animals. D retrovirus is not infectious to people.


Other Enteric Bacteria and Parasites

  • Yersinia enterocolitica is more rare than the previously mentioned pathogens, but can also cause severe diarrhea and dehydration in people and monkeys.
  • Salmonella is not common in nonhuman primates. Infection can occur from contact with an infected person or from consumption of contaminated food, especially poultry. Mild or severe diarrhea can occur.
  • Escherichia coli occasionally causes diarrhea which may either watery or contain blood and mucous. Giardia lamblia, Cryptosporidium parvum, Enterocytozoan bieneusi, Balantridium coli, and Entameba histolytica are all intestinal protozoa that can infect monkeys and man. Diarrhea can range from mild to severe. These parasites are rare in most laboratory primates.
  • Wild-caught monkeys occasionally harbor other parasites that can infect people.

Home
 
ARCM, Harvard Medical School, 665 Huntington Avenue, Boston, MA 02115, arcm@hms.harvard.edu
Submit feedback on web site
© 2002 by the President and Fellows of Harvard College

Getting Started
Training & Information
Animals In & Out
Health & Husbandry
Regulations & Compliance
Occupational Health
About ARCM
www.hms.harvard.edu